Home > Balance Sheet > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
AD     Remove this Ad

KILITCH DRUGS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹25 Cr₹-2.39 Cr₹-1.91 Cr₹-1.24 Cr₹-0.90 Cr

What is the latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) ?

The latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) is ₹25 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹25 Cr
Mar2024₹-2.39 Cr
Mar2023₹-1.91 Cr
Mar2022₹-1.24 Cr
Mar2021₹-0.90 Cr

How is Total Non-Current Liabilities of KILITCH DRUGS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹25 Cr
Positive
Mar2024 ₹-2.39 Cr
Negative
Mar2023 ₹-1.91 Cr
Negative
Mar2022 ₹-1.24 Cr
Negative
Mar2021 ₹-0.90 Cr -

Compare Total Non-Current Liabilities of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹650.1 Cr 13.4% 5.8% 15.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

13.4%

5.8%

15.7%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses